Skip to main content
. 2021 Aug;8(8):696–707. doi: 10.1016/S2215-0366(21)00158-9

Table 3.

Effect of treatment on putative mediators

Befriending (n=66) The Feeling Safe Programme (n=64) Adjusted difference*(95% CI, SE); p value Cohen d (95% CI)
Possibility of being mistaken
Baseline 19·92 (20·90), n=66 19·20 (21·21), n=64 .. ..
6 months 36·80 (28·07), n=61 48·11 (34·65), n=61 13·92 (4·47); p=0·002 (5·17 to 22·68) 0·66 (0·25 to 1·08)
12 months 35·05 (30·76), n=62 47·16 (33·98), n=57 12·53 (4·52); p=0·006 (3·67 to 21·40) 0·60 (0·17 to 1·02)
Vulnerability
Baseline 75·15 (23·26), n=66 72·28 (24·07), n=64 .. ..
6 months 63·7 (26·89), n=62 49·31 (32·24), n=61 −12·67 (4·73); p=0·007 (−21·94 to −3·40) −0·54 (−0·93 to −0·14)
12 months 56·73 (2733), n=62 47·77 (31·07), n=57 −7·20 (4·81); p=0·134 (−16·63 to 2·23) −0·30 (−0·70 to 0·09)
BCSS positive others
Baseline 9·60 (4·14), n=65 9·11 (4·90), n=62 .. ..
6 months 10·05 (4·17), n=61 12·20 (5·96), n=54 2·24 (0·71); p=0·002 (0·84 to 3·64) 0·50 (0·19 to 0·81)
12 months 9·98 (4·41), n=59 11·15 (5·40), n=52 0·98 (0·73); p=0·176 (−0·44 to 2·40) 0·22 (−0·10 to 0·53)
Insomnia
Baseline 14·02 (6·36), n=65 13·52 (7·4), n=61 .. ..
6 months 12·25 (6·81), n=60 8·5 (6·21), n=52 −2·98 (0·97); p=0·002 (−4·88 to −1·09) −0·43 (−0·71 to −0·16)
12 months 13·32 (6·60), n=57 10·17 (6·78), n=52 −2·02 (0·97); p=0·037 (−3·92 to −0·13) −0·29 (−0·57 to −0·02)
PSWQ total (worry)
Baseline 63·26 (11·27), n=65 62·58 (10·68), n=62 .. ..
6 months 57·35 (12·78), n=60 54·25 (15·51), n=52 −3·33 (1·67); p=0·046 (−6·59 to −0·06) −0·30 (−0·60 to −0·01)
12 months 58·30 (12·21), n=57 54·65 (11·34), n=52 −3·11 (1·68); p=0·064 (−6·40 to 0·18) −0·28 (−0·58 to 0·02)
BCSS negative self
Baseline 11·98 (5·77), n=65 11·81 (5·31), n=62 .. ..
6 months 9·11 (5·79), n=61 7·78 (5·84), n=54 −1·63 (0·78); p=0·038 (−3·16 to −0·09) −0·29 (−0·57 to −0·02)
12 months 9·53 (6·27), n=58 8·46 (5·84), n=52 −1·15 (0·80); p=0·151 (−2·72 to 0·42) −0·21 (−0·49 to 0·08)
Jumping to conclusions
Baseline 4·14 (4·47), n=63 3·50 (3·2), n=56 .. ..
6 months 4·98 (4·62), n=55 3·57 (3·34), n=51 −1·12 (0·55); p=0·041 (−2·20 to −0·05) −0·28 (−0·56 to −0·01)
12 months 4·49 (3·91), n=51 4·08 (3·26), n=39 −0·19 (0·58); p=0·750 (−1·33 to 0·96) −0·05 (−0·34 to 0·24)
BCSS positive self
Baseline 7·35 (4·65), n=66 7·84 (5·17), n=62 .. ..
6 months 8·43 (5·15), n=61 9·93 (5·53), n=54 1·26 (0·74); p=0·088 (−0·19 to 2·70) 0·26 (−0·04 to 0·55)
12 months 9·09 (4·73), n=58 9·19 (6·23), n=52 −0·48 (0·76); p=0·527 (−1·96 to 1·00) −0·10 (−0·40 to 0·20)
BCSS negative others
Baseline 13·89 (5·33), n=64 14·34 (5·15), n=62 .. ..
6 months 9·74 (6·39), n=61 8·87 (6·40), n=54 −1·30 (0·79); p=0·097 (−2·84 to 0·24) −0·25 (−0·54 to 0·04)
12 months 11·32 (6·17), n=59 9·08 (6·56), n=52 −2·34 (0·80); p=0·003 (−3·90 to −0·78) −0·45 (−0·75 to −0·15)
Safety beliefs
Baseline 37·88 (29·64), n=65 37·75 (26·34), n=64 .. ..
6 months 50·67 (28·71), n=63 55·62 (29·41), n=61 6·52 (4·46); p=0·144 (−2·23 to 15·27) 0·23 (−0·08 to 0·55)
12 months 49·03 (29·47), n=62 57·00 (28·58), n=57 8·09 (4·54); p=0·075 (−0·80 to 16·99) 0·29 (−0·03 to 0·61)
Safety behaviours
Baseline 34·14 (16·58), n=65 33·85 (16·91), n=62 .. ..
6 months 21·98 (16·54), n=58 19·85 (18·49), n=52 −2·22 (2·40); p=0·355 (−6·93 to 2·48) −0·13 (−0·42 to 0·15)
12 months 20·78 (15·46), n=54 18·73 (13·35), n=45 −1·41 (2·51); p=0·574 (−6·34 to 3·51) −0·08 (−0·38 to 0·21)
Anomalous experiences
Baseline 21·80 (15·02), n=65 22·38 (14·63), n=64 .. ..
6 months 15·57 (12·87), n=61 16·34 (14·93), n=59 −0·76 (1·46); p=0·604 (−3·61 to 2·10) −0·05 (−0·24 to 0·14)
12 months 14·37 (12·97), n=60 19·16 (15·61), n=57 2·02 (1·48); p=0·171 (−0·87 to 4·92) 0·14 (−0·06 to 0·33)

Data are unadjusted mean (SD) or n (%), unless otherwise specified. BCSS=Brief Core Schema Scales. PSWQ=Penn State Worry Questionnaire.

*

Adjusted for baseline score, therapist, interaction of timepoint with treatment allocation, and for including a random effect at the individual level.

End of treatment statistically significant findings.

End of treatment non-statistically significant findings.